You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
锺南山:大规模接种新冠疫苗需时
阿思达克 11-27 14:10
内媒报道,首届中国卫生健康科技创新发展大会在深圳召开,中国工程院院士锺南山表示,辉瑞(PFE.US)及Moderna(MRNA.US)疫苗的结果出来仅三个多月,对於一个新的疫苗,这时间是远远不够。

锺南山指,中国也在积极推动新冠肺炎疫苗快速研发,提高其安全性和有效性,有关估计不会太长,就会有一个初步结果。

他称发展一个新的疫苗至少要五年以上,但目前的疫苗都未满一年,都有些缺点,因此鼓励发展比较多类型的疫苗,并认为有必要生产一些紧急疫苗,但大规模地接种还需要时间。(ek/k) ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account